Concepedia

Kerstin Malmström

KM

23

Publications

2.9K

Citations

21

H-Index

1975

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

École Polytechnique Fédérale de Lausanne

ETH Zurich

Pharmaceutical Product Development (United States)

Kerstin Malmström is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, physiology, and metabolism.

Top concepts

Publications per year

1975–2005

23

Publications

23

Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma

Kerstin Malmström · Annals of Internal Medicine · 1999 · 619 citations

Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma

Michel Laviolette, Kerstin Malmström, Susan Lu et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 353 citations

Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist

Sven‐Erik Dahlén, Kerstin Malmström, Ewa Niżankowska et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 317 citations

, , +9

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial

Eli O. Meltzer, Kerstin Malmström, Susan Lu et al. · Journal of Allergy and Clinical Immunology · 2000 · 308 citations · Full text

, , +6

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial

Kerstin Malmström, Stephen Daniels, Paul Kotey et al. · Clinical Therapeutics · 1999 · 261 citations

, , +10

Rows per page

1–5 of 23